Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Cancer Research|October 2, 2024
Resistance Management for Cancer: Lessons from FarmersSareh Seyedi, Valerie K Harris, Stefania E Kapsetaki, et al.
JAMA Network Open|February 18, 2022
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical TrialNiharika B Mettu, Fang-Shu Ou, Tyler J Zemla, et al.
Cancer|November 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 studyCody Eslinger, Daniel Walden, Alexandra Krivonos, et al.
JCO Precision Oncology|November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo ClinicOudai Sahwan, Fares Jamal, Rish Pai, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 2025
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and RecurrenceReetesh K Pai, Cody Eslinger, Kenneth Lee, et al.
Clinical Colorectal Cancer|December 12, 2022
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C StudyManish A Shah, Takayuki Yoshino, Niall C Tebbutt, et al.
The New England Journal of Medicine|May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal CancerElena Elez, Takayuki Yoshino, Lin Shen, et al.
Nature Biotechnology|October 1, 2025
Derivation of embryonic stem cells across avian speciesXi Chen, Zheng Guo, Xinyi Tong, et al.
Research Square|January 10, 2024
Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)Kathryn E Hitchcock, Eric D Miller, Qian Shi, et al.
Pageof 14